---
figid: PMC10820227__pharmaceuticals-17-00043-g007
figtitle: Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through
  the ESR2/PI3K/AKT Signalling Pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10820227
filename: PMC10820227__pharmaceuticals-17-00043-g007.jpg
figlink: /pmc/articles/PMC10820227/figure/F7
number: F7
caption: ESR2/PI3K/AKT signalling pathway
papertitle: Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through
  the ESR2/PI3K/AKT Signalling Pathway
reftext: Fenglin Luo, et al. Pharmaceuticals (Basel). 2024 Jan;17(1).
year: '2024'
doi: 10.3390/ph17010043
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI
keywords: colorectal cancer | Isoliquiritigenin | network pharmacology | ESR2 | PI3K/AKT
  pathway
automl_pathway: 0.9105467
figid_alias: PMC10820227__F7
figtype: Figure
redirect_from: /figures/PMC10820227__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10820227__pharmaceuticals-17-00043-g007.html
  '@type': Dataset
  description: ESR2/PI3K/AKT signalling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ESR2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - BCL2
---
